Global Avian Influenza Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Avian Influenza Vaccines market size was valued at US$ 1188 million in 2025 and is forecast to a readjusted size of US$ 1706 million by 2032 with a CAGR of 5.4% during review period.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
This report is a detailed and comprehensive analysis for global Avian Influenza Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Avian Influenza Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Avian Influenza Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Avian Influenza Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Avian Influenza Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Avian Influenza Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Avian Influenza Vaccines, with price, sales quantity, revenue, and global market share of Avian Influenza Vaccines from 2021 to 2026.
Chapter 3, the Avian Influenza Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Avian Influenza Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Avian Influenza Vaccines.
Chapter 14 and 15, to describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
This report is a detailed and comprehensive analysis for global Avian Influenza Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Avian Influenza Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2021-2032
Global Avian Influenza Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Avian Influenza Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Avian Influenza Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Avian Influenza Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- H5+H7 Avian Influenza Vaccines
- H9 Avian Influenza Vaccines
- Chicken
- Duck & Goose
- Other
- Boehringer Ingelheim
- CAHIC
- DHN
- HVRI
- CEVA
- Elanco Animal Health
- Zoetis
- FATRO
- Kyoto Biken
- CAVAC
- Ringpu Biology
- Vaksindo
- Sindh Poultry Vaccine Centre
- Merck Animal Health
- PT Medion Farma Jaya
- Avimex Animal Health
- JOVAC
- Bio-Labs
- Pusvetma
- IPB-Shigeta
- Medion Farma Jaya
- Caprifamarindo
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Avian Influenza Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Avian Influenza Vaccines, with price, sales quantity, revenue, and global market share of Avian Influenza Vaccines from 2021 to 2026.
Chapter 3, the Avian Influenza Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Avian Influenza Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Avian Influenza Vaccines.
Chapter 14 and 15, to describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Avian Influenza Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 H5+H7 Avian Influenza Vaccines
1.3.3 H9 Avian Influenza Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Avian Influenza Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Chicken
1.4.3 Duck & Goose
1.4.4 Other
1.5 Global Avian Influenza Vaccines Market Size & Forecast
1.5.1 Global Avian Influenza Vaccines Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Avian Influenza Vaccines Sales Quantity (2021-2032)
1.5.3 Global Avian Influenza Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Avian Influenza Vaccines Product and Services
2.1.4 Boehringer Ingelheim Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 CAHIC
2.2.1 CAHIC Details
2.2.2 CAHIC Major Business
2.2.3 CAHIC Avian Influenza Vaccines Product and Services
2.2.4 CAHIC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CAHIC Recent Developments/Updates
2.3 DHN
2.3.1 DHN Details
2.3.2 DHN Major Business
2.3.3 DHN Avian Influenza Vaccines Product and Services
2.3.4 DHN Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 DHN Recent Developments/Updates
2.4 HVRI
2.4.1 HVRI Details
2.4.2 HVRI Major Business
2.4.3 HVRI Avian Influenza Vaccines Product and Services
2.4.4 HVRI Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 HVRI Recent Developments/Updates
2.5 CEVA
2.5.1 CEVA Details
2.5.2 CEVA Major Business
2.5.3 CEVA Avian Influenza Vaccines Product and Services
2.5.4 CEVA Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CEVA Recent Developments/Updates
2.6 Elanco Animal Health
2.6.1 Elanco Animal Health Details
2.6.2 Elanco Animal Health Major Business
2.6.3 Elanco Animal Health Avian Influenza Vaccines Product and Services
2.6.4 Elanco Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Elanco Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Avian Influenza Vaccines Product and Services
2.7.4 Zoetis Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Zoetis Recent Developments/Updates
2.8 FATRO
2.8.1 FATRO Details
2.8.2 FATRO Major Business
2.8.3 FATRO Avian Influenza Vaccines Product and Services
2.8.4 FATRO Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 FATRO Recent Developments/Updates
2.9 Kyoto Biken
2.9.1 Kyoto Biken Details
2.9.2 Kyoto Biken Major Business
2.9.3 Kyoto Biken Avian Influenza Vaccines Product and Services
2.9.4 Kyoto Biken Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Kyoto Biken Recent Developments/Updates
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business
2.10.3 CAVAC Avian Influenza Vaccines Product and Services
2.10.4 CAVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 CAVAC Recent Developments/Updates
2.11 Ringpu Biology
2.11.1 Ringpu Biology Details
2.11.2 Ringpu Biology Major Business
2.11.3 Ringpu Biology Avian Influenza Vaccines Product and Services
2.11.4 Ringpu Biology Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Ringpu Biology Recent Developments/Updates
2.12 Vaksindo
2.12.1 Vaksindo Details
2.12.2 Vaksindo Major Business
2.12.3 Vaksindo Avian Influenza Vaccines Product and Services
2.12.4 Vaksindo Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Vaksindo Recent Developments/Updates
2.13 Sindh Poultry Vaccine Centre
2.13.1 Sindh Poultry Vaccine Centre Details
2.13.2 Sindh Poultry Vaccine Centre Major Business
2.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
2.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
2.14 Merck Animal Health
2.14.1 Merck Animal Health Details
2.14.2 Merck Animal Health Major Business
2.14.3 Merck Animal Health Avian Influenza Vaccines Product and Services
2.14.4 Merck Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Merck Animal Health Recent Developments/Updates
2.15 PT Medion Farma Jaya
2.15.1 PT Medion Farma Jaya Details
2.15.2 PT Medion Farma Jaya Major Business
2.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Product and Services
2.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 PT Medion Farma Jaya Recent Developments/Updates
2.16 Avimex Animal Health
2.16.1 Avimex Animal Health Details
2.16.2 Avimex Animal Health Major Business
2.16.3 Avimex Animal Health Avian Influenza Vaccines Product and Services
2.16.4 Avimex Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Avimex Animal Health Recent Developments/Updates
2.17 JOVAC
2.17.1 JOVAC Details
2.17.2 JOVAC Major Business
2.17.3 JOVAC Avian Influenza Vaccines Product and Services
2.17.4 JOVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 JOVAC Recent Developments/Updates
2.18 Bio-Labs
2.18.1 Bio-Labs Details
2.18.2 Bio-Labs Major Business
2.18.3 Bio-Labs Avian Influenza Vaccines Product and Services
2.18.4 Bio-Labs Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Bio-Labs Recent Developments/Updates
2.19 Pusvetma
2.19.1 Pusvetma Details
2.19.2 Pusvetma Major Business
2.19.3 Pusvetma Avian Influenza Vaccines Product and Services
2.19.4 Pusvetma Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Pusvetma Recent Developments/Updates
2.20 IPB-Shigeta
2.20.1 IPB-Shigeta Details
2.20.2 IPB-Shigeta Major Business
2.20.3 IPB-Shigeta Avian Influenza Vaccines Product and Services
2.20.4 IPB-Shigeta Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 IPB-Shigeta Recent Developments/Updates
2.21 Medion Farma Jaya
2.21.1 Medion Farma Jaya Details
2.21.2 Medion Farma Jaya Major Business
2.21.3 Medion Farma Jaya Avian Influenza Vaccines Product and Services
2.21.4 Medion Farma Jaya Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Medion Farma Jaya Recent Developments/Updates
2.22 Caprifamarindo
2.22.1 Caprifamarindo Details
2.22.2 Caprifamarindo Major Business
2.22.3 Caprifamarindo Avian Influenza Vaccines Product and Services
2.22.4 Caprifamarindo Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Caprifamarindo Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AVIAN INFLUENZA VACCINES BY MANUFACTURER
3.1 Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Avian Influenza Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Avian Influenza Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Avian Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Avian Influenza Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Avian Influenza Vaccines Manufacturer Market Share in 2025
3.5 Avian Influenza Vaccines Market: Overall Company Footprint Analysis
3.5.1 Avian Influenza Vaccines Market: Region Footprint
3.5.2 Avian Influenza Vaccines Market: Company Product Type Footprint
3.5.3 Avian Influenza Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Avian Influenza Vaccines Market Size by Region
4.1.1 Global Avian Influenza Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Avian Influenza Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Avian Influenza Vaccines Average Price by Region (2021-2032)
4.2 North America Avian Influenza Vaccines Consumption Value (2021-2032)
4.3 Europe Avian Influenza Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Avian Influenza Vaccines Consumption Value (2021-2032)
4.5 South America Avian Influenza Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Avian Influenza Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Avian Influenza Vaccines Consumption Value by Type (2021-2032)
5.3 Global Avian Influenza Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Avian Influenza Vaccines Consumption Value by Application (2021-2032)
6.3 Global Avian Influenza Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Avian Influenza Vaccines Market Size by Country
7.3.1 North America Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Avian Influenza Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Avian Influenza Vaccines Market Size by Country
8.3.1 Europe Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Avian Influenza Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Avian Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Avian Influenza Vaccines Market Size by Country
10.3.1 South America Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Avian Influenza Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Avian Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Avian Influenza Vaccines Market Drivers
12.2 Avian Influenza Vaccines Market Restraints
12.3 Avian Influenza Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Avian Influenza Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Avian Influenza Vaccines
13.3 Avian Influenza Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Avian Influenza Vaccines Typical Distributors
14.3 Avian Influenza Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Avian Influenza Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 H5+H7 Avian Influenza Vaccines
1.3.3 H9 Avian Influenza Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Avian Influenza Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Chicken
1.4.3 Duck & Goose
1.4.4 Other
1.5 Global Avian Influenza Vaccines Market Size & Forecast
1.5.1 Global Avian Influenza Vaccines Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Avian Influenza Vaccines Sales Quantity (2021-2032)
1.5.3 Global Avian Influenza Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Avian Influenza Vaccines Product and Services
2.1.4 Boehringer Ingelheim Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 CAHIC
2.2.1 CAHIC Details
2.2.2 CAHIC Major Business
2.2.3 CAHIC Avian Influenza Vaccines Product and Services
2.2.4 CAHIC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CAHIC Recent Developments/Updates
2.3 DHN
2.3.1 DHN Details
2.3.2 DHN Major Business
2.3.3 DHN Avian Influenza Vaccines Product and Services
2.3.4 DHN Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 DHN Recent Developments/Updates
2.4 HVRI
2.4.1 HVRI Details
2.4.2 HVRI Major Business
2.4.3 HVRI Avian Influenza Vaccines Product and Services
2.4.4 HVRI Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 HVRI Recent Developments/Updates
2.5 CEVA
2.5.1 CEVA Details
2.5.2 CEVA Major Business
2.5.3 CEVA Avian Influenza Vaccines Product and Services
2.5.4 CEVA Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CEVA Recent Developments/Updates
2.6 Elanco Animal Health
2.6.1 Elanco Animal Health Details
2.6.2 Elanco Animal Health Major Business
2.6.3 Elanco Animal Health Avian Influenza Vaccines Product and Services
2.6.4 Elanco Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Elanco Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Avian Influenza Vaccines Product and Services
2.7.4 Zoetis Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Zoetis Recent Developments/Updates
2.8 FATRO
2.8.1 FATRO Details
2.8.2 FATRO Major Business
2.8.3 FATRO Avian Influenza Vaccines Product and Services
2.8.4 FATRO Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 FATRO Recent Developments/Updates
2.9 Kyoto Biken
2.9.1 Kyoto Biken Details
2.9.2 Kyoto Biken Major Business
2.9.3 Kyoto Biken Avian Influenza Vaccines Product and Services
2.9.4 Kyoto Biken Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Kyoto Biken Recent Developments/Updates
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business
2.10.3 CAVAC Avian Influenza Vaccines Product and Services
2.10.4 CAVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 CAVAC Recent Developments/Updates
2.11 Ringpu Biology
2.11.1 Ringpu Biology Details
2.11.2 Ringpu Biology Major Business
2.11.3 Ringpu Biology Avian Influenza Vaccines Product and Services
2.11.4 Ringpu Biology Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Ringpu Biology Recent Developments/Updates
2.12 Vaksindo
2.12.1 Vaksindo Details
2.12.2 Vaksindo Major Business
2.12.3 Vaksindo Avian Influenza Vaccines Product and Services
2.12.4 Vaksindo Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Vaksindo Recent Developments/Updates
2.13 Sindh Poultry Vaccine Centre
2.13.1 Sindh Poultry Vaccine Centre Details
2.13.2 Sindh Poultry Vaccine Centre Major Business
2.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
2.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
2.14 Merck Animal Health
2.14.1 Merck Animal Health Details
2.14.2 Merck Animal Health Major Business
2.14.3 Merck Animal Health Avian Influenza Vaccines Product and Services
2.14.4 Merck Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Merck Animal Health Recent Developments/Updates
2.15 PT Medion Farma Jaya
2.15.1 PT Medion Farma Jaya Details
2.15.2 PT Medion Farma Jaya Major Business
2.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Product and Services
2.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 PT Medion Farma Jaya Recent Developments/Updates
2.16 Avimex Animal Health
2.16.1 Avimex Animal Health Details
2.16.2 Avimex Animal Health Major Business
2.16.3 Avimex Animal Health Avian Influenza Vaccines Product and Services
2.16.4 Avimex Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Avimex Animal Health Recent Developments/Updates
2.17 JOVAC
2.17.1 JOVAC Details
2.17.2 JOVAC Major Business
2.17.3 JOVAC Avian Influenza Vaccines Product and Services
2.17.4 JOVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 JOVAC Recent Developments/Updates
2.18 Bio-Labs
2.18.1 Bio-Labs Details
2.18.2 Bio-Labs Major Business
2.18.3 Bio-Labs Avian Influenza Vaccines Product and Services
2.18.4 Bio-Labs Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Bio-Labs Recent Developments/Updates
2.19 Pusvetma
2.19.1 Pusvetma Details
2.19.2 Pusvetma Major Business
2.19.3 Pusvetma Avian Influenza Vaccines Product and Services
2.19.4 Pusvetma Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Pusvetma Recent Developments/Updates
2.20 IPB-Shigeta
2.20.1 IPB-Shigeta Details
2.20.2 IPB-Shigeta Major Business
2.20.3 IPB-Shigeta Avian Influenza Vaccines Product and Services
2.20.4 IPB-Shigeta Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 IPB-Shigeta Recent Developments/Updates
2.21 Medion Farma Jaya
2.21.1 Medion Farma Jaya Details
2.21.2 Medion Farma Jaya Major Business
2.21.3 Medion Farma Jaya Avian Influenza Vaccines Product and Services
2.21.4 Medion Farma Jaya Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Medion Farma Jaya Recent Developments/Updates
2.22 Caprifamarindo
2.22.1 Caprifamarindo Details
2.22.2 Caprifamarindo Major Business
2.22.3 Caprifamarindo Avian Influenza Vaccines Product and Services
2.22.4 Caprifamarindo Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Caprifamarindo Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AVIAN INFLUENZA VACCINES BY MANUFACTURER
3.1 Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Avian Influenza Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Avian Influenza Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Avian Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Avian Influenza Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Avian Influenza Vaccines Manufacturer Market Share in 2025
3.5 Avian Influenza Vaccines Market: Overall Company Footprint Analysis
3.5.1 Avian Influenza Vaccines Market: Region Footprint
3.5.2 Avian Influenza Vaccines Market: Company Product Type Footprint
3.5.3 Avian Influenza Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Avian Influenza Vaccines Market Size by Region
4.1.1 Global Avian Influenza Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Avian Influenza Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Avian Influenza Vaccines Average Price by Region (2021-2032)
4.2 North America Avian Influenza Vaccines Consumption Value (2021-2032)
4.3 Europe Avian Influenza Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Avian Influenza Vaccines Consumption Value (2021-2032)
4.5 South America Avian Influenza Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Avian Influenza Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Avian Influenza Vaccines Consumption Value by Type (2021-2032)
5.3 Global Avian Influenza Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Avian Influenza Vaccines Consumption Value by Application (2021-2032)
6.3 Global Avian Influenza Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Avian Influenza Vaccines Market Size by Country
7.3.1 North America Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Avian Influenza Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Avian Influenza Vaccines Market Size by Country
8.3.1 Europe Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Avian Influenza Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Avian Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Avian Influenza Vaccines Market Size by Country
10.3.1 South America Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Avian Influenza Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Avian Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Avian Influenza Vaccines Market Drivers
12.2 Avian Influenza Vaccines Market Restraints
12.3 Avian Influenza Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Avian Influenza Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Avian Influenza Vaccines
13.3 Avian Influenza Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Avian Influenza Vaccines Typical Distributors
14.3 Avian Influenza Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Avian Influenza Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Avian Influenza Vaccines Product and Services
Table 6. Boehringer Ingelheim Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. CAHIC Basic Information, Manufacturing Base and Competitors
Table 9. CAHIC Major Business
Table 10. CAHIC Avian Influenza Vaccines Product and Services
Table 11. CAHIC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. CAHIC Recent Developments/Updates
Table 13. DHN Basic Information, Manufacturing Base and Competitors
Table 14. DHN Major Business
Table 15. DHN Avian Influenza Vaccines Product and Services
Table 16. DHN Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. DHN Recent Developments/Updates
Table 18. HVRI Basic Information, Manufacturing Base and Competitors
Table 19. HVRI Major Business
Table 20. HVRI Avian Influenza Vaccines Product and Services
Table 21. HVRI Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. HVRI Recent Developments/Updates
Table 23. CEVA Basic Information, Manufacturing Base and Competitors
Table 24. CEVA Major Business
Table 25. CEVA Avian Influenza Vaccines Product and Services
Table 26. CEVA Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. CEVA Recent Developments/Updates
Table 28. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Elanco Animal Health Major Business
Table 30. Elanco Animal Health Avian Influenza Vaccines Product and Services
Table 31. Elanco Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Elanco Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Avian Influenza Vaccines Product and Services
Table 36. Zoetis Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Zoetis Recent Developments/Updates
Table 38. FATRO Basic Information, Manufacturing Base and Competitors
Table 39. FATRO Major Business
Table 40. FATRO Avian Influenza Vaccines Product and Services
Table 41. FATRO Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. FATRO Recent Developments/Updates
Table 43. Kyoto Biken Basic Information, Manufacturing Base and Competitors
Table 44. Kyoto Biken Major Business
Table 45. Kyoto Biken Avian Influenza Vaccines Product and Services
Table 46. Kyoto Biken Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Kyoto Biken Recent Developments/Updates
Table 48. CAVAC Basic Information, Manufacturing Base and Competitors
Table 49. CAVAC Major Business
Table 50. CAVAC Avian Influenza Vaccines Product and Services
Table 51. CAVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. CAVAC Recent Developments/Updates
Table 53. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 54. Ringpu Biology Major Business
Table 55. Ringpu Biology Avian Influenza Vaccines Product and Services
Table 56. Ringpu Biology Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Ringpu Biology Recent Developments/Updates
Table 58. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 59. Vaksindo Major Business
Table 60. Vaksindo Avian Influenza Vaccines Product and Services
Table 61. Vaksindo Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Vaksindo Recent Developments/Updates
Table 63. Sindh Poultry Vaccine Centre Basic Information, Manufacturing Base and Competitors
Table 64. Sindh Poultry Vaccine Centre Major Business
Table 65. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
Table 66. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Sindh Poultry Vaccine Centre Recent Developments/Updates
Table 68. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 69. Merck Animal Health Major Business
Table 70. Merck Animal Health Avian Influenza Vaccines Product and Services
Table 71. Merck Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Merck Animal Health Recent Developments/Updates
Table 73. PT Medion Farma Jaya Basic Information, Manufacturing Base and Competitors
Table 74. PT Medion Farma Jaya Major Business
Table 75. PT Medion Farma Jaya Avian Influenza Vaccines Product and Services
Table 76. PT Medion Farma Jaya Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. PT Medion Farma Jaya Recent Developments/Updates
Table 78. Avimex Animal Health Basic Information, Manufacturing Base and Competitors
Table 79. Avimex Animal Health Major Business
Table 80. Avimex Animal Health Avian Influenza Vaccines Product and Services
Table 81. Avimex Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Avimex Animal Health Recent Developments/Updates
Table 83. JOVAC Basic Information, Manufacturing Base and Competitors
Table 84. JOVAC Major Business
Table 85. JOVAC Avian Influenza Vaccines Product and Services
Table 86. JOVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. JOVAC Recent Developments/Updates
Table 88. Bio-Labs Basic Information, Manufacturing Base and Competitors
Table 89. Bio-Labs Major Business
Table 90. Bio-Labs Avian Influenza Vaccines Product and Services
Table 91. Bio-Labs Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Bio-Labs Recent Developments/Updates
Table 93. Pusvetma Basic Information, Manufacturing Base and Competitors
Table 94. Pusvetma Major Business
Table 95. Pusvetma Avian Influenza Vaccines Product and Services
Table 96. Pusvetma Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Pusvetma Recent Developments/Updates
Table 98. IPB-Shigeta Basic Information, Manufacturing Base and Competitors
Table 99. IPB-Shigeta Major Business
Table 100. IPB-Shigeta Avian Influenza Vaccines Product and Services
Table 101. IPB-Shigeta Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. IPB-Shigeta Recent Developments/Updates
Table 103. Medion Farma Jaya Basic Information, Manufacturing Base and Competitors
Table 104. Medion Farma Jaya Major Business
Table 105. Medion Farma Jaya Avian Influenza Vaccines Product and Services
Table 106. Medion Farma Jaya Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Medion Farma Jaya Recent Developments/Updates
Table 108. Caprifamarindo Basic Information, Manufacturing Base and Competitors
Table 109. Caprifamarindo Major Business
Table 110. Caprifamarindo Avian Influenza Vaccines Product and Services
Table 111. Caprifamarindo Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 112. Caprifamarindo Recent Developments/Updates
Table 113. Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 114. Global Avian Influenza Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 115. Global Avian Influenza Vaccines Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 116. Market Position of Manufacturers in Avian Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 117. Head Office and Avian Influenza Vaccines Production Site of Key Manufacturer
Table 118. Avian Influenza Vaccines Market: Company Product Type Footprint
Table 119. Avian Influenza Vaccines Market: Company Product Application Footprint
Table 120. Avian Influenza Vaccines New Market Entrants and Barriers to Market Entry
Table 121. Avian Influenza Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Avian Influenza Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 123. Global Avian Influenza Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 124. Global Avian Influenza Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 125. Global Avian Influenza Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Global Avian Influenza Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 127. Global Avian Influenza Vaccines Average Price by Region (2021-2026) & (USD/K Doses)
Table 128. Global Avian Influenza Vaccines Average Price by Region (2027-2032) & (USD/K Doses)
Table 129. Global Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 130. Global Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 131. Global Avian Influenza Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 132. Global Avian Influenza Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 133. Global Avian Influenza Vaccines Average Price by Type (2021-2026) & (USD/K Doses)
Table 134. Global Avian Influenza Vaccines Average Price by Type (2027-2032) & (USD/K Doses)
Table 135. Global Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 136. Global Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 137. Global Avian Influenza Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 138. Global Avian Influenza Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 139. Global Avian Influenza Vaccines Average Price by Application (2021-2026) & (USD/K Doses)
Table 140. Global Avian Influenza Vaccines Average Price by Application (2027-2032) & (USD/K Doses)
Table 141. North America Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 142. North America Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 143. North America Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 144. North America Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 145. North America Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 146. North America Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 147. North America Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 148. North America Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Europe Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 150. Europe Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 151. Europe Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 152. Europe Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 153. Europe Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 154. Europe Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 155. Europe Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 156. Europe Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 157. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 158. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 159. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 160. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 161. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 162. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 163. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 164. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 165. South America Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 166. South America Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 167. South America Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 168. South America Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 169. South America Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 170. South America Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 171. South America Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 172. South America Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 174. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 175. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 176. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 177. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 178. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 179. Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 180. Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 181. Avian Influenza Vaccines Raw Material
Table 182. Key Manufacturers of Avian Influenza Vaccines Raw Materials
Table 183. Avian Influenza Vaccines Typical Distributors
Table 184. Avian Influenza Vaccines Typical Customers
Table 1. Global Avian Influenza Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Avian Influenza Vaccines Product and Services
Table 6. Boehringer Ingelheim Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. CAHIC Basic Information, Manufacturing Base and Competitors
Table 9. CAHIC Major Business
Table 10. CAHIC Avian Influenza Vaccines Product and Services
Table 11. CAHIC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. CAHIC Recent Developments/Updates
Table 13. DHN Basic Information, Manufacturing Base and Competitors
Table 14. DHN Major Business
Table 15. DHN Avian Influenza Vaccines Product and Services
Table 16. DHN Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. DHN Recent Developments/Updates
Table 18. HVRI Basic Information, Manufacturing Base and Competitors
Table 19. HVRI Major Business
Table 20. HVRI Avian Influenza Vaccines Product and Services
Table 21. HVRI Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. HVRI Recent Developments/Updates
Table 23. CEVA Basic Information, Manufacturing Base and Competitors
Table 24. CEVA Major Business
Table 25. CEVA Avian Influenza Vaccines Product and Services
Table 26. CEVA Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. CEVA Recent Developments/Updates
Table 28. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Elanco Animal Health Major Business
Table 30. Elanco Animal Health Avian Influenza Vaccines Product and Services
Table 31. Elanco Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Elanco Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Avian Influenza Vaccines Product and Services
Table 36. Zoetis Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Zoetis Recent Developments/Updates
Table 38. FATRO Basic Information, Manufacturing Base and Competitors
Table 39. FATRO Major Business
Table 40. FATRO Avian Influenza Vaccines Product and Services
Table 41. FATRO Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. FATRO Recent Developments/Updates
Table 43. Kyoto Biken Basic Information, Manufacturing Base and Competitors
Table 44. Kyoto Biken Major Business
Table 45. Kyoto Biken Avian Influenza Vaccines Product and Services
Table 46. Kyoto Biken Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Kyoto Biken Recent Developments/Updates
Table 48. CAVAC Basic Information, Manufacturing Base and Competitors
Table 49. CAVAC Major Business
Table 50. CAVAC Avian Influenza Vaccines Product and Services
Table 51. CAVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. CAVAC Recent Developments/Updates
Table 53. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 54. Ringpu Biology Major Business
Table 55. Ringpu Biology Avian Influenza Vaccines Product and Services
Table 56. Ringpu Biology Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Ringpu Biology Recent Developments/Updates
Table 58. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 59. Vaksindo Major Business
Table 60. Vaksindo Avian Influenza Vaccines Product and Services
Table 61. Vaksindo Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Vaksindo Recent Developments/Updates
Table 63. Sindh Poultry Vaccine Centre Basic Information, Manufacturing Base and Competitors
Table 64. Sindh Poultry Vaccine Centre Major Business
Table 65. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
Table 66. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Sindh Poultry Vaccine Centre Recent Developments/Updates
Table 68. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 69. Merck Animal Health Major Business
Table 70. Merck Animal Health Avian Influenza Vaccines Product and Services
Table 71. Merck Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Merck Animal Health Recent Developments/Updates
Table 73. PT Medion Farma Jaya Basic Information, Manufacturing Base and Competitors
Table 74. PT Medion Farma Jaya Major Business
Table 75. PT Medion Farma Jaya Avian Influenza Vaccines Product and Services
Table 76. PT Medion Farma Jaya Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. PT Medion Farma Jaya Recent Developments/Updates
Table 78. Avimex Animal Health Basic Information, Manufacturing Base and Competitors
Table 79. Avimex Animal Health Major Business
Table 80. Avimex Animal Health Avian Influenza Vaccines Product and Services
Table 81. Avimex Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Avimex Animal Health Recent Developments/Updates
Table 83. JOVAC Basic Information, Manufacturing Base and Competitors
Table 84. JOVAC Major Business
Table 85. JOVAC Avian Influenza Vaccines Product and Services
Table 86. JOVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. JOVAC Recent Developments/Updates
Table 88. Bio-Labs Basic Information, Manufacturing Base and Competitors
Table 89. Bio-Labs Major Business
Table 90. Bio-Labs Avian Influenza Vaccines Product and Services
Table 91. Bio-Labs Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Bio-Labs Recent Developments/Updates
Table 93. Pusvetma Basic Information, Manufacturing Base and Competitors
Table 94. Pusvetma Major Business
Table 95. Pusvetma Avian Influenza Vaccines Product and Services
Table 96. Pusvetma Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Pusvetma Recent Developments/Updates
Table 98. IPB-Shigeta Basic Information, Manufacturing Base and Competitors
Table 99. IPB-Shigeta Major Business
Table 100. IPB-Shigeta Avian Influenza Vaccines Product and Services
Table 101. IPB-Shigeta Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. IPB-Shigeta Recent Developments/Updates
Table 103. Medion Farma Jaya Basic Information, Manufacturing Base and Competitors
Table 104. Medion Farma Jaya Major Business
Table 105. Medion Farma Jaya Avian Influenza Vaccines Product and Services
Table 106. Medion Farma Jaya Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Medion Farma Jaya Recent Developments/Updates
Table 108. Caprifamarindo Basic Information, Manufacturing Base and Competitors
Table 109. Caprifamarindo Major Business
Table 110. Caprifamarindo Avian Influenza Vaccines Product and Services
Table 111. Caprifamarindo Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 112. Caprifamarindo Recent Developments/Updates
Table 113. Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2021-2026) & (M Doses)
Table 114. Global Avian Influenza Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 115. Global Avian Influenza Vaccines Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 116. Market Position of Manufacturers in Avian Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 117. Head Office and Avian Influenza Vaccines Production Site of Key Manufacturer
Table 118. Avian Influenza Vaccines Market: Company Product Type Footprint
Table 119. Avian Influenza Vaccines Market: Company Product Application Footprint
Table 120. Avian Influenza Vaccines New Market Entrants and Barriers to Market Entry
Table 121. Avian Influenza Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Avian Influenza Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 123. Global Avian Influenza Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 124. Global Avian Influenza Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 125. Global Avian Influenza Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Global Avian Influenza Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 127. Global Avian Influenza Vaccines Average Price by Region (2021-2026) & (USD/K Doses)
Table 128. Global Avian Influenza Vaccines Average Price by Region (2027-2032) & (USD/K Doses)
Table 129. Global Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 130. Global Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 131. Global Avian Influenza Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 132. Global Avian Influenza Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 133. Global Avian Influenza Vaccines Average Price by Type (2021-2026) & (USD/K Doses)
Table 134. Global Avian Influenza Vaccines Average Price by Type (2027-2032) & (USD/K Doses)
Table 135. Global Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 136. Global Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 137. Global Avian Influenza Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 138. Global Avian Influenza Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 139. Global Avian Influenza Vaccines Average Price by Application (2021-2026) & (USD/K Doses)
Table 140. Global Avian Influenza Vaccines Average Price by Application (2027-2032) & (USD/K Doses)
Table 141. North America Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 142. North America Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 143. North America Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 144. North America Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 145. North America Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 146. North America Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 147. North America Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 148. North America Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Europe Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 150. Europe Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 151. Europe Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 152. Europe Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 153. Europe Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 154. Europe Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 155. Europe Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 156. Europe Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 157. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 158. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 159. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 160. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 161. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2021-2026) & (M Doses)
Table 162. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2027-2032) & (M Doses)
Table 163. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 164. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 165. South America Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 166. South America Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 167. South America Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 168. South America Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 169. South America Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 170. South America Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 171. South America Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 172. South America Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2021-2026) & (M Doses)
Table 174. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2027-2032) & (M Doses)
Table 175. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2021-2026) & (M Doses)
Table 176. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2027-2032) & (M Doses)
Table 177. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2021-2026) & (M Doses)
Table 178. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2027-2032) & (M Doses)
Table 179. Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 180. Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 181. Avian Influenza Vaccines Raw Material
Table 182. Key Manufacturers of Avian Influenza Vaccines Raw Materials
Table 183. Avian Influenza Vaccines Typical Distributors
Table 184. Avian Influenza Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Avian Influenza Vaccines Picture
Figure 2. Global Avian Influenza Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Avian Influenza Vaccines Revenue Market Share by Type in 2025
Figure 4. H5+H7 Avian Influenza Vaccines Examples
Figure 5. H9 Avian Influenza Vaccines Examples
Figure 6. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Avian Influenza Vaccines Revenue Market Share by Application in 2025
Figure 8. Chicken Examples
Figure 9. Duck & Goose Examples
Figure 10. Other Examples
Figure 11. Global Avian Influenza Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Avian Influenza Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Avian Influenza Vaccines Sales Quantity (2021-2032) & (M Doses)
Figure 14. Global Avian Influenza Vaccines Price (2021-2032) & (USD/K Doses)
Figure 15. Global Avian Influenza Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Avian Influenza Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Avian Influenza Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Avian Influenza Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Avian Influenza Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Avian Influenza Vaccines Average Price by Type (2021-2032) & (USD/K Doses)
Figure 30. Global Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032)
Figure 32. Global Avian Influenza Vaccines Average Price by Application (2021-2032) & (USD/K Doses)
Figure 33. North America Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 45. France Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Avian Influenza Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 53. China Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 56. India Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 73. Avian Influenza Vaccines Market Drivers
Figure 74. Avian Influenza Vaccines Market Restraints
Figure 75. Avian Influenza Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2025
Figure 78. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 79. Avian Influenza Vaccines Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Avian Influenza Vaccines Picture
Figure 2. Global Avian Influenza Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Avian Influenza Vaccines Revenue Market Share by Type in 2025
Figure 4. H5+H7 Avian Influenza Vaccines Examples
Figure 5. H9 Avian Influenza Vaccines Examples
Figure 6. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Avian Influenza Vaccines Revenue Market Share by Application in 2025
Figure 8. Chicken Examples
Figure 9. Duck & Goose Examples
Figure 10. Other Examples
Figure 11. Global Avian Influenza Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Avian Influenza Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Avian Influenza Vaccines Sales Quantity (2021-2032) & (M Doses)
Figure 14. Global Avian Influenza Vaccines Price (2021-2032) & (USD/K Doses)
Figure 15. Global Avian Influenza Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Avian Influenza Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Avian Influenza Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Avian Influenza Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Avian Influenza Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Avian Influenza Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Avian Influenza Vaccines Average Price by Type (2021-2032) & (USD/K Doses)
Figure 30. Global Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032)
Figure 32. Global Avian Influenza Vaccines Average Price by Application (2021-2032) & (USD/K Doses)
Figure 33. North America Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 45. France Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Avian Influenza Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 53. China Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 56. India Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Avian Influenza Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Avian Influenza Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 73. Avian Influenza Vaccines Market Drivers
Figure 74. Avian Influenza Vaccines Market Restraints
Figure 75. Avian Influenza Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2025
Figure 78. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 79. Avian Influenza Vaccines Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
